COVID-19 act as a Catalyst in the Growth of Respiratory Devices Market

DELTA, British Columbia - Aug. 7, 2020 - PRLog -- The intensifying prevalence of chronic respiratory diseases, mushrooming geriatric population specially in Japan coupled with technological advancements are few the major reasons for growth of digital respiratory medical devices in the Asia Pacific region. The mounting predominance of respiratory disorders such as asthma and Chronic Obstructive Pulmonary Disease (COPD) in India and China are inducing the need for digital medical respiratory devices over the past 3 years. According to MarkNtel Advisors' research report "Asia-Pacific Digital Respiratory Medical Device Market Analysis, 2020", the market size of digital respiratory medical devices in Asia-Pacific region is anticipated to grow at a CAGR of around 30% during 2020-25.

View Report: https://bit.ly/3gocAF7

"Asia-Pacific Digital Respiratory Medical Device Market Analysis, 2020" provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for digital Respiratory Medical Device providers across the region. Moreover, the report also encompasses the key strategic imperatives for success along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This would help companies in the formulation of Go to Market Strategies.

Impact of Covid-19
The grappling situation and continuous rise in death toll is accentuating the demand for respiratory devices as the patients dealing with this novel disease are found to have an acute breathing problem. This would have a sudden rise in the procurement of respiratory devices both by the government and private sector under healthcare services. Several Governments and other healthcare providers have planned capacity expansion in terms of the number of beds to cope up with the increasing COVID-19 cases. Moreover, both the market stakeholders are anticipated to increase precautionary spending, which would result in increased number of digital respiratory devices.

Market Segmentation:

• By Product (Therapeutic Devices, Diagnostics Monitoring Devices, Consumables and Accessories Respiratory Therapy Wearable Medical Device, Disposals),
•  By End-User (Home Care and Hospitals & Clinics)
• By Indication (Chronic Obstructive Pulmonary Disease, Sleep Apnea, Asthma, Infectious Disease),
• By Country (China, India, Japan, South Korea, Australia),
• By Company (3M, Cohero Health, Novartis, Glenmark, NuvoAir, Medical International Research, Nonin, AstraZeneca Plc, GE Healthcare, Masimo Corporation, etc)